Chemoinformaics analysis of 3,12-DIHYDROXYHEXADECANOIC ACID
| Molecular Weight | 288.428 | nRot | 14 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 1 |
| Exact Molecular Weight | 288.23 | nRing | 0 |
| Solubility: LogS | -3.332 | nHRing | 0 |
| Solubility: LogP | 3.567 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 51.2654 |
| nHD | 3 | BPOL | 32.9706 |
| QED | 0.428 |
| Synth | 2.878 |
| Natural Product Likeliness | 0.969 |
| NR-PPAR-gamma | 0.984 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.091 |
| HIA | 0.206 |
| CACO-2 | -5.213 |
| MDCK | 0.0000465 |
| BBB | 0.588 |
| PPB | 0.900928 |
| VDSS | 0.388 |
| FU | 0.0669621 |
| CYP1A2-inh | 0.042 |
| CYP1A2-sub | 0.479 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.469 |
| CYP2c9-inh | 0.059 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.071 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.028 |
| CL | 10.957 |
| T12 | 0.796 |
| hERG | 0.019 |
| Ames | 0.007 |
| ROA | 0.003 |
| SkinSen | 0.654 |
| Carcinogencity | 0.058 |
| EI | 0.96 |
| Respiratory | 0.113 |
| NR-Aromatase | 0.11 |
| Antiviral | Yes |
| Prediction | 0.683317 |